What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?
作者信息
Zarate Carlos A
机构信息
Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD.
出版信息
Am J Geriatr Psychiatry. 2017 Nov;25(11):1210-1212. doi: 10.1016/j.jagp.2017.08.009. Epub 2017 Aug 30.
Abstract
摘要
相似文献
1
What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments?老年重度抑郁症患者对所有治疗均无反应时应如何处理？
Am J Geriatr Psychiatry. 2017 Nov;25(11):1210-1212. doi: 10.1016/j.jagp.2017.08.009. Epub 2017 Aug 30.
2
Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study.S-氯胺酮作为丙泊酚麻醉佐剂对治疗难治性抑郁症患者电休克治疗反应的影响：一项随机先导研究。
J ECT. 2013 Sep;29(3):158-61. doi: 10.1097/YCT.0b013e318283b7e9.
3
Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder.治疗抵抗性重度抑郁症患者注射氯胺酮后中脑边缘奖赏系统反应性增加。
Anesthesiology. 2019 Jun;130(6):923-935. doi: 10.1097/ALN.0000000000002667.
4
Intravenous arketamine for treatment-resistant depression: open-label pilot study.静脉注射氯胺酮治疗难治性抑郁症：开放标签试点研究。
Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):577-582. doi: 10.1007/s00406-020-01110-5. Epub 2020 Feb 20.
5
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.氯胺酮用于难治性单相和双相重度抑郁症：批判性综述及对临床实践的启示
Depress Anxiety. 2016 Aug;33(8):698-710. doi: 10.1002/da.22505. Epub 2016 Apr 6.
6
Ketamine administration in depressive disorders: a systematic review and meta-analysis.氯胺酮在抑郁症治疗中的应用：一项系统综述和荟萃分析。
Psychopharmacology (Berl). 2014 Sep;231(18):3663-76. doi: 10.1007/s00213-014-3664-5. Epub 2014 Jul 20.
7
A response to: Repeated intranasal ketamine for treatment resistant depression: The way to go? Results from a pilot randomised controlled trial.
J Psychopharmacol. 2019 Feb;33(2):258-259. doi: 10.1177/0269881118822160.
8
Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study.氯胺酮维持治疗难治性抑郁症：一项开放性试点研究。
Braz J Psychiatry. 2018 Jan-Mar;40(1):110. doi: 10.1590/1516-4446-2017-2380.
9
A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial.
J Psychopharmacol. 2019 Feb;33(2):260-261. doi: 10.1177/0269881118822147.
10
Synergistic use of deep TMS therapy with IV ketamine infusions for major depressive disorder: a pilot study.深部经颅磁刺激治疗联合静脉注射氯胺酮治疗重度抑郁症：一项初步研究。
Psychopharmacology (Berl). 2024 Jul;241(7):1427-1433. doi: 10.1007/s00213-024-06573-1. Epub 2024 Mar 12.
引用本文的文献
1
Ketamine for resistant depression: a scoping review.氯胺酮治疗抵抗性抑郁症：范围综述。
Actas Esp Psiquiatr. 2022 May;50(3):144-159. Epub 2022 May 1.
本文引用的文献
1
Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression.标题：皮下注射氯胺酮滴定治疗对治疗抵抗性老年抑郁症患者的随机对照试验
Am J Geriatr Psychiatry. 2017 Nov;25(11):1199-1209. doi: 10.1016/j.jagp.2017.06.007. Epub 2017 Jun 13.
2
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.抗抑郁药换药与增效对难治性重度抑郁症患者缓解率的影响：VAST-D随机临床试验
JAMA. 2017 Jul 11;318(2):132-145. doi: 10.1001/jama.2017.8036.
3
Suicide Means among Decedents Aged 50+ Years, 2005-2014: Trends and Associations with Sociodemographic and Precipitating Factors.2005-2014 年 50 岁及以上死者的自杀手段：趋势及与社会人口学和促成因素的关联。
Am J Geriatr Psychiatry. 2017 Dec;25(12):1404-1414. doi: 10.1016/j.jagp.2017.06.001. Epub 2017 Jul 6.
4
Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder.急性氯胺酮给药纠正重度抑郁症中的异常炎症性骨标志物。
Mol Psychiatry. 2018 Jul;23(7):1626-1631. doi: 10.1038/mp.2017.109. Epub 2017 May 30.
5
Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders.平衡氯胺酮治疗情绪障碍的前景与风险
Neuropsychopharmacology. 2017 May;42(6):1179-1181. doi: 10.1038/npp.2016.193. Epub 2016 Sep 19.
6
Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.老年抑郁症的右侧单侧超短脉冲电休克治疗：PRIDE研究的第一阶段。
Am J Psychiatry. 2016 Nov 1;173(11):1101-1109. doi: 10.1176/appi.ajp.2016.15081101. Epub 2016 Jul 15.
7
The role of adipokines in the rapid antidepressant effects of ketamine.脂肪因子在氯胺酮快速抗抑郁作用中的作用。
Mol Psychiatry. 2017 Jan;22(1):127-133. doi: 10.1038/mp.2016.36. Epub 2016 Apr 5.
8
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.氯胺酮的抗快感缺失作用及其在难治性双相抑郁中的神经关联
Transl Psychiatry. 2014 Oct 14;4(10):e469. doi: 10.1038/tp.2014.105.
9
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.氯胺酮治疗难治性重度抑郁症的疗效：一项双中心随机对照试验。
Am J Psychiatry. 2013 Oct;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.
10
Older adults with severe, treatment-resistant depression.患有严重、治疗抵抗性抑郁症的老年人。
JAMA. 2012 Sep 5;308(9):909-18. doi: 10.1001/2012.jama.10690.
Zotero 插件